HTFL HEARTFLOW INC

Heartflow to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Heartflow to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

MOUNTAIN VIEW, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that members of management will participate in a fireside chat at the upcoming Morgan Stanley 23rd Annual Global Healthcare Conference. The fireside chat will take place on Wednesday, September 10, 2025, at 6:15 a.m. PT / 9:15 a.m. ET.

A live and archived version of the fireside chat will be available on the Investor Relations section of the Heartflow website at .

About Heartflow, Inc.

Heartflow is advancing coronary care by transforming coronary artery disease into a screenable, diagnosable, and manageable condition. Heartflow One is the only complete, non-invasive, precision coronary care platform providing patient insights throughout the guideline-directed CCTA pathway. The AI-driven platform — including Roadmap™ Analysis, FFRCT Analysis and Plaque Analysis — is supported by the ACC/AHA Chest Pain Guideline and backed by more than 600 peer-reviewed publications. Heartflow has helped clinicians manage over 400,000 patients worldwide. Discover how we’re shaping the future of cardiovascular care at .

Investor Contact

Nick Laudico

Media Contact

Elliot Levy



EN
27/08/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on HEARTFLOW INC

 PRESS RELEASE

Heartflow to Participate in the Morgan Stanley Technology, Media & Tel...

Heartflow to Participate in the Morgan Stanley Technology, Media & Telecom Conference MOUNTAIN VIEW, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that members of management will participate in a fireside chat at the upcoming Morgan Stanley Technology, Media & Telecom Conference. The presentation will take place in San Francisco, CA, on Tuesday, March 3, 2026, at 10:45 a.m. PT / 1:45 p.m. ET. A live and archived version of the fireside chat will be available on the Inves...

 PRESS RELEASE

Heartflow to Report Fourth Quarter and Full Year 2025 Financial Result...

Heartflow to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026 MOUNTAIN VIEW, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will release financial results for the fourth quarter and full year of 2025 after market close on Wednesday, March 18, 2026. Management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET on March 18, 2026. Those interested in listening to the conference call should . Once r...

 PRESS RELEASE

Heartflow Expands GAMEFILM Registry to NBA and NHL Alumni, Precisely M...

Heartflow Expands GAMEFILM Registry to NBA and NHL Alumni, Precisely Measuring Heart Disease Risk in Former Professional Athletes NBA legend Muggsy Bogues joins effort to detect and manage coronary artery disease in retired players using AI-powered Heartflow Analysis MOUNTAIN VIEW, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced a significant expansion of its groundbreaking . Building on a successful initial phase enrolling retired National Football League (NFL) athletes, the study will...

 PRESS RELEASE

Heartflow Plaque Analysis Now Covered by Aetna Insurance Plans Nationw...

Heartflow Plaque Analysis Now Covered by Aetna Insurance Plans Nationwide and for the Majority of Insured Lives in the U.S. Fourth major national payer releases positive comprehensive coverage for AI-powered Heartflow Plaque Analysis MOUNTAIN VIEW, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced is now covered by Aetna across all lines of business, including Commercial, Medicare Advantage, and Aetna Better Health Medicaid plans. Aetna is the fourth major national commercial insurer to ...

 PRESS RELEASE

Heartflow to Participate in the 44th Annual J.P. Morgan Healthcare Con...

Heartflow to Participate in the 44th Annual J.P. Morgan Healthcare Conference MOUNTAIN VIEW, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in artificial intelligence (AI) technology for coronary artery disease (CAD), today announced that members of management will present at the upcoming 44th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Tuesday, January 13, 2026, at 1:30 p.m. PT / 4:30 p.m. ET. A live and archived version of the presentation will be available on the Investor Relations section of the Heart...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch